AR070975A1 - Tratamiento para trastornos relacionados con los ojos, composicion y uso - Google Patents
Tratamiento para trastornos relacionados con los ojos, composicion y usoInfo
- Publication number
- AR070975A1 AR070975A1 ARP090100835A ARP090100835A AR070975A1 AR 070975 A1 AR070975 A1 AR 070975A1 AR P090100835 A ARP090100835 A AR P090100835A AR P090100835 A ARP090100835 A AR P090100835A AR 070975 A1 AR070975 A1 AR 070975A1
- Authority
- AR
- Argentina
- Prior art keywords
- treatment
- eye
- composition
- related disorders
- compound
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Ophthalmology & Optometry (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Tratamiento para trastornos relacionados con los ojos, tales como la degeneracion macular, y preferentemente degeneracion macular asociada a la edad, retinopatía diabética, y edema macular diabético, utilizando un compuesto de Formula 1 o una sal farmacéuticamente aceptable o profármaco del mismo Reivindicacion 8: El método de la reivindicacion 1, en el que el compuesto de formula 1 se administra a un paciente que está siendo concurrentemente tratado con ranizumab.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3507308P | 2008-03-10 | 2008-03-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR070975A1 true AR070975A1 (es) | 2010-05-19 |
Family
ID=40583469
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP090100835A AR070975A1 (es) | 2008-03-10 | 2009-03-09 | Tratamiento para trastornos relacionados con los ojos, composicion y uso |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP2285378A1 (es) |
| JP (1) | JP2011513488A (es) |
| KR (1) | KR20110009084A (es) |
| CN (1) | CN101965188A (es) |
| AR (1) | AR070975A1 (es) |
| AU (1) | AU2009223501A1 (es) |
| BR (1) | BRPI0909659A2 (es) |
| CA (1) | CA2717991A1 (es) |
| CL (1) | CL2009000551A1 (es) |
| CO (1) | CO6290691A2 (es) |
| CR (1) | CR11644A (es) |
| DO (1) | DOP2010000266A (es) |
| IL (1) | IL207906A0 (es) |
| MA (1) | MA32211B1 (es) |
| MX (1) | MX2010008308A (es) |
| NI (1) | NI201000131A (es) |
| NZ (1) | NZ587906A (es) |
| RU (1) | RU2010141560A (es) |
| SV (1) | SV2010003658A (es) |
| TW (1) | TW200950784A (es) |
| WO (1) | WO2009114373A1 (es) |
| ZA (1) | ZA201005337B (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW201034675A (en) | 2008-12-18 | 2010-10-01 | Sanofi Aventis | Method for treating macular degeneration |
| EP2441755A1 (en) | 2010-09-30 | 2012-04-18 | Almirall, S.A. | Pyridine- and isoquinoline-derivatives as Syk and JAK kinase inhibitors |
| EP2489663A1 (en) | 2011-02-16 | 2012-08-22 | Almirall, S.A. | Compounds as syk kinase inhibitors |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1263759B1 (en) * | 1999-12-24 | 2010-09-08 | Aventis Pharma Limited | Azaindoles |
| AU778417B2 (en) * | 2000-02-25 | 2004-12-02 | Merck & Co., Inc. | Tyrosine kinase inhibitors |
| KR101487027B1 (ko) * | 2005-09-30 | 2015-01-28 | 미카나 테라퓨틱스, 인크. | 치환된 피라졸 화합물 |
| CL2007002617A1 (es) * | 2006-09-11 | 2008-05-16 | Sanofi Aventis | Compuestos derivados de pirrolo[2,3-b]pirazin-6-ilo; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar inflamacion de las articulaciones, artritis reumatoide, tumores, linfoma de las celulas del manto. |
-
2009
- 2009-03-05 RU RU2010141560/15A patent/RU2010141560A/ru unknown
- 2009-03-05 MX MX2010008308A patent/MX2010008308A/es not_active Application Discontinuation
- 2009-03-05 JP JP2010550758A patent/JP2011513488A/ja not_active Withdrawn
- 2009-03-05 KR KR1020107019973A patent/KR20110009084A/ko not_active Application Discontinuation
- 2009-03-05 CN CN2009801075816A patent/CN101965188A/zh active Pending
- 2009-03-05 BR BRPI0909659A patent/BRPI0909659A2/pt not_active IP Right Cessation
- 2009-03-05 NZ NZ587906A patent/NZ587906A/en not_active IP Right Cessation
- 2009-03-05 WO PCT/US2009/036119 patent/WO2009114373A1/en active Application Filing
- 2009-03-05 EP EP09718970A patent/EP2285378A1/en not_active Withdrawn
- 2009-03-05 AU AU2009223501A patent/AU2009223501A1/en not_active Abandoned
- 2009-03-05 CA CA2717991A patent/CA2717991A1/en not_active Abandoned
- 2009-03-09 AR ARP090100835A patent/AR070975A1/es not_active Application Discontinuation
- 2009-03-09 CL CL2009000551A patent/CL2009000551A1/es unknown
- 2009-03-09 TW TW098107567A patent/TW200950784A/zh unknown
-
2010
- 2010-07-27 ZA ZA2010/05337A patent/ZA201005337B/en unknown
- 2010-07-29 NI NI201000131A patent/NI201000131A/es unknown
- 2010-08-24 CR CR11644A patent/CR11644A/es not_active Application Discontinuation
- 2010-08-31 IL IL207906A patent/IL207906A0/en unknown
- 2010-09-01 CO CO10108103A patent/CO6290691A2/es not_active Application Discontinuation
- 2010-09-02 DO DO2010000266A patent/DOP2010000266A/es unknown
- 2010-09-07 SV SV2010003658A patent/SV2010003658A/es unknown
- 2010-10-06 MA MA33226A patent/MA32211B1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2011513488A (ja) | 2011-04-28 |
| NZ587906A (en) | 2011-12-22 |
| MA32211B1 (fr) | 2011-04-01 |
| CA2717991A1 (en) | 2009-09-17 |
| CN101965188A (zh) | 2011-02-02 |
| KR20110009084A (ko) | 2011-01-27 |
| RU2010141560A (ru) | 2012-04-20 |
| CR11644A (es) | 2010-11-22 |
| NI201000131A (es) | 2011-09-29 |
| ZA201005337B (en) | 2011-04-28 |
| IL207906A0 (en) | 2010-12-30 |
| CO6290691A2 (es) | 2011-06-20 |
| MX2010008308A (es) | 2010-08-11 |
| WO2009114373A1 (en) | 2009-09-17 |
| CL2009000551A1 (es) | 2009-08-21 |
| DOP2010000266A (es) | 2010-09-30 |
| SV2010003658A (es) | 2011-01-31 |
| AU2009223501A1 (en) | 2009-09-17 |
| EP2285378A1 (en) | 2011-02-23 |
| TW200950784A (en) | 2009-12-16 |
| BRPI0909659A2 (pt) | 2015-09-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR120961A2 (es) | Método y composición para tratar hipertensión ocular y glaucoma | |
| CO2019007810A2 (es) | Compuestos de amino-triazolopiridina y su uso en el tratamiento del cáncer | |
| DOP2014000008A (es) | 4-imidazopiridazina-1-il-benzamidas y 4-imidazotriazina-1-il-benzamidas como inhibidores de btk | |
| AR075729A1 (es) | Derivados de benzofuranilo, composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento de la obesidad y/o diabetes. | |
| GT201500030A (es) | Análogos de piridazina 1,4-disustituida y métodos para el tratamiento de condiciones relacionadas con la deficiencia de smn | |
| UY31676A1 (es) | "derivados de 3-metil-imidiazo-[1,2-b]-piridazina" | |
| CL2009001554A1 (es) | Compuestos derivados de 4-(sulfonilaminoalquilamino)-n-fenil-n'-hidroxi-1,2,5-oxadiazol-3-carboximidamida; formas cristalinas; procesos de preparacion; compuestos intermediarios; composicion farmaceutica; y su uso para el tratamiento de enfermedades tales como cancer, infeccion viral, depresion, entre otras. | |
| EA201590053A1 (ru) | Модуляторы пути системы комплемента и их применение | |
| SV2011003939A (es) | Piridiloxi-indoles inhibidores del vegf-r2 y uso de los mismos para el tratamiento de enfermedades | |
| TN2011000437A1 (en) | Substituted azoanthracene derivatives, pharmaceutical compositions, and methods of use thereof | |
| BR112013028534A2 (pt) | compostos tricíclicos parcialmente saturados e métodos para produção e utilização dos mesmos | |
| CR20140086A (es) | Tratamientos de combinación para hepatitis c | |
| GT201200164A (es) | "nuevos compuestos de espiropiperidina" | |
| PE20121520A1 (es) | Formulacion farmaceutica que comprende ranolazina y dronedarona en el tratamiento de fibrilacion auricular | |
| DOP2015000169A (es) | Compuestos tetracíclicos sustituidos con heterociclo y usos de los mismos para el tratamiento de enfermedades víricas | |
| CO2018009561A2 (es) | Métodos para tratar la depresión con antagonistas del receptor de orexina-2 | |
| UY31554A1 (es) | Nuevos inhibidores de acetil coenzima a carboxilasa y usos en tratamientos de obesidad y diabetes mellitus | |
| ECSP10010428A (es) | Derivados de indazol | |
| EA200970944A1 (ru) | Применение биполярных транскаротиноидов в качестве предварительного лечения при лечении заболевания периферических сосудов | |
| UY39559A (es) | Compuestos y su uso | |
| MX2014002112A (es) | Compuestos de pirimido-piridazinona y uso de los mismos. | |
| UY31672A1 (es) | "agonistas de receptores muscarínicos composiciones farmacéuticas métodos de tratamiento de los mismos, y procedimientos para su preparación" | |
| UY32829A (es) | Derivados de 3-heteroaril-metil-imidazo-[1,2-b]-pirididazin - 6 -ilo | |
| AR070975A1 (es) | Tratamiento para trastornos relacionados con los ojos, composicion y uso | |
| PE20181450A1 (es) | Compuestos de 1,3,4-tiadiazol y su uso en el tratamiento del cancer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |